fashion -WSS

fashion

author：hotspot 2025-10-02 21:00:28 - browse：5269

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Key House panel plots a new health care package

WSS

FDA approves RSV monoclonal antibody for infants, toddlers

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Ohioans vote in high

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

hotspot

fashion

knowledge

Psychedelics group wrestles with new pharma identity

STAT Virtual Event: The State of Biosimilars: What to Watch

Medicare proposal to cover medical devices draws a mixed reaction

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Guidelines to prevent youth baseball injuries need more muscle

How Medicaid coverage policies for immigrants impact new moms

Duchenne breakthrough therapy leaves behind pioneering families

An Ebola outbreak presents a new mystery involving children

Medicare details structure of new drug price negotiation program

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

knowledge

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

STAT Virtual Event: The State of Biosimilars: What to Watch

Listen: Wegovy in the brain & pivotal Alzheimer's data

Sanders adds drug shortage policies to pandemic preparedness bill

Former Georgia lieutenant governor says he received grand jury subpoena

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

knowledge

focus

leisure time

leisure time